In our study, we evaluated the prognostic value of MMP2 expression in melanoma, the OS of patients with high MMP2 expression was significantly lower than patients with low MMP2 expression, and this trend was more pronounced in patients with BRAF mutation. The gene discussed is MMP2; the disease is melanoma.